Pink SheetEurope’s Unified Patent Court has given its first insight into how it will handle infringements of second medical use claims, after its verdict in the showdown between Sanofi/Regeneron Pharmaceuticals
ScripWhile significant progress has been made in the treatment of non-small cell lung cancer (NSCLC), small-cell lung cancer (SCLC) has seen fewer advances and patients continue to have limited treatment o
ScripThe 2025 American Society of Clinical Oncology conference will take place in Chicago from 30 May-3 June, and while it typically leans toward solid tumors, it also often features a number of important
ScripRoyalty Pharma has built a unique and valuable business model within the biopharma sector, buying royalty revenue streams in exchange for capital to finance drug development and commercialization. And